Fibrinogen, Plasminogen Activator Inhibitor-1, and Carotid Intima-Media Wall Thickness in the NHLBI Family Heart Study
- 1 January 1998
- journal article
- letter
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 79 (02) , 400-404
Abstract
Several studies have linked higher plasma fibrinogen and plasminogen activator inhibitor (PAI-1) concentrations with increased risk of cardiovascular disease. We studied whether members of families with increased occurrence of coronary heart disease (CHD) have increased levels of fibrinogen and PAI-1 and whether subclinical carotid atherosclerosis is associated with these two hemostatic factors. Contrary to our hypothesis, fibrinogen and PAI-1 antigen levels were not different between high CHD risk families versus random families. Adjusted for age and family type, fibrinogen and PAI-1 were both associated positively with carotid intima-media thickness assessed by B-mode ultrasound. However, adjustment for lifestyle and medical covariates essentially eliminated these associations. These data suggest 1) elevated fibrinogen and PAI-1 do not explain clustering of CHD in families and 2) fibrinogen and PAI-1 may partly mediate the effects of other risk factors on carotid atherosclerosis, though the data are also consistent with them playing no causal role.Keywords
Funding Information
- Blood Institute (N01-HC-25104, N01-HC-25105, N01-HC-25106, N01-HC-25107, N01-HC-25108, and N01-HC-25109)
This publication has 21 references indexed in Scilit:
- Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina PectorisCirculation, 1996
- NHLBI Family Heart Study: Objectives and DesignAmerican Journal of Epidemiology, 1996
- Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic diseaseBlood Coagulation & Fibrinolysis, 1994
- Genetic Susceptibility to Death from Coronary Heart Disease in a Study of TwinsNew England Journal of Medicine, 1994
- Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation, 1991
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984